Fierce Biotech

FDA rejects Regenxbio's gene therapy in Hunter syndrome, leaving CEO 'concerned'

After facing a delayed decision deadline and a clinical hold, Regenxbio’s Hunter syndrome gene therapy has been rejected by ...
Fierce Biotech

Lilly, Innovent pen $8.8B oncology, immunology collab that 'moves beyond traditional licensing'

Eli Lilly is heading back to its regular Chinese collaborator Innovent Biologics with $350 million in upfront cash to ...
Fierce Biotech

CSL signs on to $328M research collab with option for Memo's immunoglobulin antibody tech

CSL has gotten the Memo about the value of recombinant polyclonal immunoglobulin (IgG) antibodies.  | The deal allows CSL to ...
Fierce Biotech

Roche unveils data behind BTK inhibitor's phase 3 multiple sclerosis win in Ocrevus trial

Roche has shared the numbers behind its phase 3 win in primary progressive multiple sclerosis (PPMS), linking its BTK ...
Fierce Biotech

Takeda inks $1.7B AI drug discovery deal with Iambic Therapeutics

After sharing word that it would be prioritizing artificial intelligence to aid discovery work, Takeda Pharmaceuticals has inked a multiyear deal to access Iambic Therapeutics' broad suite of& | ...
Fierce Biotech

FDA slaps highest-risk recall notice on J&J Medtech Cerepak detachable coils

The FDA has flagged J&J Medtech’s recall of its Cerepak detachable coils as Class I in the wake of one death and four serious injuries. | The FDA has flagged J&J Medtech’s recall of Cerepak detachable ...
Fierce Biotech

Bristol Myers and Evinova pen global development partnership

Bristol Myers Squibb is partnering up with Evinova’s AI clinical development platform across the Big Pharma company’s global portfolio in an effort to improve efficiency and cut costs.